EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Androgen and Estrogen β Receptor Expression Enhances Efficacy of Antihormonal Treatments in Triple-Negative Breast Cancer Cell Lines

Belen Crespo iD, Juan Carlos Illera, Gema Silvan, Paula Lopez-Plaza, María Herrera de la Muela, Miriam de la Puente Yagüe iD, Cristina Diaz Del Arco iD, Maria Jose Illera, Sara Caceres iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25031471 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Belen Crespo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department Animal Physiology, Veterinary Medicine School, Complutense University of Madrid (UCM), 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Androgens, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencias, Innovación y Universidades. Instituto de Salud Carlos III..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The triple-negative breast cancer (TNBC) subtype is characterized by the lack of expression of ERα (estrogen receptor α), PR (progesterone receptor) and no overexpression of HER-2. However, TNBC can express the androgen receptor (AR) or estrogen receptor β (ERβ). Also, TNBC secretes steroid hormones and is influenced by hormonal fluctuations, so the steroid inhibition could exert a beneficial effect in TNBC treatment. The aim of this study was to evaluate the effect of dutasteride, anastrozole and ASP9521 in in vitro processes using human TNBC cell lines. For this, immunofluorescence, sensitivity, proliferation and wound healing assays were performed, and hormone concentrations were studied. Results revealed that all TNBC cell lines expressed AR and ERβ; the ones that expressed them most intensely were more sensitive to antihormonal treatments. All treatments reduced cell viability, highlighting MDA-MB-453 and SUM-159. Indeed, a decrease in androgen levels was observed in these cell lines, which could relate to a reduction in cell viability. In addition, MCF-7 and SUM-159 increased cell migration under treatments, increasing estrogen levels, which could favor cell migration. Thus, antihormonal treatments could be beneficial for TNBC therapies. This study clarifies the importance of steroid hormones in AR and ERβ-positive cell lines of TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AndrogensTriple Negative Breast NeoplasmsHumansReceptors, EstrogenEstrogen Receptor betaCell Line, TumorEstrogensReceptors, AndrogenSteroidsEstrogen Receptor alphaCell Proliferation

Stichwörter der Autor:innen

androgen receptorestrogen receptor betasteroid pathwaytriple-negative breast cancer

Substanzen

AndrogensReceptors, EstrogenEstrogen Receptor betaEstrogensReceptors, AndrogenSteroidsEstrogen Receptor alpha

Autor:innen und Institutionen

  • Department Animal Physiology, Veterinary Medicine School, Complutense University of Madrid (UCM), 28040 Madrid, Spain.
  • Obstetrics and Gynecology Department, Hospital Clinico San Carlos, Instituto de Salud de la Mujer, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IsISSC), 28040 Madrid, Spain.
  • Department of Public and Maternal Child Health University, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.
  • Department of Surgical Pathology, Hospital Clínico San Carlos, 28040 Madrid, Spain.

ORCID-Profile: Belen Crespo, Miriam de la Puente Yagüe, Cristina Diaz Del Arco, Sara Caceres

Förderung

  • Ministerio de Ciencias, Innovación y Universidades. Instituto de Salud Carlos III.

Zitieren

APA

Crespo, B., Illera, J. C., Silvan, G., Lopez-Plaza, P., Herrera de la Muela, M., de la Puente Yagüe, M., Diaz Del Arco, C., Illera, M. J., & Caceres, S. (2024). Androgen and Estrogen β Receptor Expression Enhances Efficacy of Antihormonal Treatments in Triple-Negative Breast Cancer Cell Lines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031471

Vancouver

Crespo B, Illera JC, Silvan G, Lopez-Plaza P, Herrera de la Muela M, de la Puente Yagüe M, et al. Androgen and Estrogen β Receptor Expression Enhances Efficacy of Antihormonal Treatments in Triple-Negative Breast Cancer Cell Lines. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031471

BibTeX
@article{Crespo2024,
  author = {Crespo, Belen and Illera, Juan Carlos and Silvan, Gema and Lopez-Plaza, Paula and Herrera de la Muela, María and de la Puente Yagüe, Miriam and Diaz Del Arco, Cristina and Illera, Maria Jose and Caceres, Sara},
  title = {Androgen and Estrogen β Receptor Expression Enhances Efficacy of Antihormonal Treatments in Triple-Negative Breast Cancer Cell Lines},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25031471}
}
Kostenlos starten →